Title: Effectiveness, safety and health-related quality of life with fingolimod treatment in multiple sclerosis: a real-world observational PERFORMS study in the Middle East Authors:
نویسندگان
چکیده
Title: Effectiveness, safety and health-related quality of life of multiple sclerosis patients treated with fingolimod: results from a 12-month, real-world, observational PERFORMS study in the Middle East Authors: Anat Achiron ([email protected]) Hany Aref ([email protected]) Jihad Inshasi ([email protected]) Mohamad Harb ([email protected]) Raed Alroughani ([email protected]) Mahendra Bijarnia ([email protected]) Kathryn Cooke ([email protected]) Ozgur Yuksel ([email protected]) Version: 2 Date: 29 May 2017 Author’s response to reviews: To Editor-in-Chief BMC Neurology
منابع مشابه
Effectiveness, safety and health-related quality of life of multiple sclerosis patients treated with fingolimod: results from a 12-month, real-world, observational PERFORMS study in the Middle East
BACKGROUND Evidence on the use of fingolimod in real-world clinical practice and data on patient-reported health-related quality of life (HRQoL) in countries such as the Middle East are sparse. The Prospective Evaluation of Treatment with Fingolimod for Multiple Sclerosis (PERFORMS) study assessed HRQoL and effectiveness and safety of fingolimod in patients with relapsing-remitting multiples sc...
متن کاملLong-term safety and real-world effectiveness of fingolimod in relapsing multiple sclerosis
With a growing number of disease-modifying therapies becoming available for relapsing multiple sclerosis, there is an important need to gather real-world evidence data regarding long-term treatment effectiveness and safety in unselected patient populations. Although not providing as high a level of evidence as randomized controlled trials, and prone to bias, real-world studies from observationa...
متن کاملOne-year Effectiveness and Side Effects of Fingolimod in Multiple Sclerosis Patients
Background and purpose: Fingolimod, is one of the first oral disease-modifying treatments (DMT) that has shown efficacy in advanced clinical trials for the treatment of multiple sclerosis (MS). The present study examined the one-year effectiveness and side effects of fingolimod. Materials and methods: In this quasi-experimental study, 26 MS patients attending Kermanshah Imam Reza Hospital wer...
متن کاملThe real-world effectiveness and safety of fingolimod in relapsing-remitting multiple sclerosis patients: An observational study
Fingolimod approval was based mainly on two clinical trials, FREEDOMS and TRANSFORMS, which demonstrated the efficacy and safety of fingolimod in patients with multiple sclerosis (MS). We present an observational study that validates these trials findings in a real-world setting, whereby the effectiveness and safety of fingolimod was assessed in Seville's' (Spain) clinical practice. This retros...
متن کاملThe PANGAEA study design – a prospective, multicenter, non-interventional, long-term study on fingolimod for the treatment of multiple sclerosis in daily practice
BACKGROUND Fingolimod (Gilenya) is an oral medication for patients with highly active relapsing-remitting Multiple Sclerosis (RRMS). Clinical trials and post-marketing experience on more than 114,000 patients have established a detailed safety profile. Total patient exposure now exceeds 195,000 patient-years as stated in the last financial report (Dec 2014) of the Novartis Pharma AG, Basel, Swi...
متن کامل